Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements

BACKGROUND: In low-risk gestational trophoblastic neoplasia (GTN) patients, a predictive marker for early identification of methotrexate (MTX) resistance would be useful. We previously demonstrated that kinetic modelling of human chorionic gonadotrophin (hCG) measurements could provide such a marker...

Descripción completa

Detalles Bibliográficos
Autores principales: You, B, Harvey, R, Henin, E, Mitchell, H, Golfier, F, Savage, P M, Tod, M, Wilbaux, M, Freyer, G, Seckl, M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664307/
https://www.ncbi.nlm.nih.gov/pubmed/23591194
http://dx.doi.org/10.1038/bjc.2013.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664307/
https://www.ncbi.nlm.nih.gov/pubmed/23591194
http://dx.doi.org/10.1038/bjc.2013.123

Ejemplares similares